For instance, data from the cancer RNAseq database indicate that GPC3 mRNA levels are diminished in breast, kidney, lung and ovarian cancers when compared to their normal counterparts, yet a stark contrast is observed in HCC where GPC3 levels are markedly elevated relative to normal liver tissues (Figure 4). This evidence concerns the gene GPC3 and ovarian cancer.